Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Amgen, Inc. (NQ: AMGN)
99.18 USD  -2.32 (-2.29%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 19, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Amgen, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Amgen Award For Science Teaching Excellence Honors Outstanding Teachers
Today 16:02 EDT
Award Demonstrates Amgen's Commitment to the Next Generation of Innovators and the Teachers who Inspire Them Read More
from PR Newswire
Amgen Joins BlackLine Systems, SAP for Webinar on Automating Account Reconciliations
Today 9:02 EDT
Director of corporate accounting from biotechnology pioneer to discuss ease of integration with SAP® solutions, benefits realized since using BlackLine, plus best practices for optimizing account recs Read More
from PR Newswire
Advanced Treatment Methods, Significant Study Results, Conferences, and Final Study Data Releases - Research Report on Amgen, Celgene, Vertex Pharmaceuticals, MannKind, and Peregrine Pharmaceuticals
June 18, 2013
Editor Note: For more information about this release, please scroll to bottom Read More
from PR Newswire
Secrets to Making Money in AMGN, PBR, PXD and GMCR
June 18, 2013
from Marketwired News Releases
The Real Story Behind AMGN, BIDU, HCP and LYB
June 17, 2013
from Marketwired News Releases
FDA Approves Amgen's XGEVA® (denosumab) For The Treatment Of Giant Cell Tumor Of Bone
June 13, 2013
XGEVA Becomes First FDA-Approved Treatment for This Rare Disease Read More
from PR Newswire
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
June 12, 2013
Study Meets Primary Endpoint of Progression-Free Survival Read More
from PR Newswire
Amgen And AstraZeneca Highlight Data To Be Presented At European League Against Rheumatism Annual Meeting
June 12, 2013
from PR Newswire
RBCC Explores New Funding for Expansion
June 10, 2013
from Business Wire News Releases
Amgen To Present At The Goldman Sachs 34th Annual Global Healthcare Conference
June 06, 2013
from PR Newswire
RBCC Poised To Gain Share Of $142 Billion Market
June 05, 2013
from Business Wire News Releases
Amgen Presents Positive Results From Talimogene Laherparepvec Phase 3 Study In Patients With Metastatic Melanoma
June 01, 2013
from PR Newswire
Free Research Reports on AMGN, C, MON and SFD Issued by the Paragon Report
May 30, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT Read More
from Marketwired News Releases
RBCC to Drive Growth Through Personalized Medicine
May 30, 2013
from Business Wire News Releases
Amgen To Webcast Investor Meeting At Upcoming American Society Of Clinical Oncology Annual Meeting
May 29, 2013
from PR Newswire
Amgen And Astellas Announce Japan Alliance
May 29, 2013
Innovative Joint Venture to Address Unmet Medical Needs of Patients in Japan Read More
from PR Newswire
ReportAlert.info - Amgen (NASDAQ:AMGN) Publishes 2012 Environmental Sustainability Report
May 28, 2013
category Amgen , environment , sustainability , and 8 more.
from 3BL Media: Corporate Social Responsibility, Energy and Health News
Critical Alerts For Amgen, Lockheed Martin, Genuine Parts, TakeTwo Interactive, and 51Job Released By InvestorsObserver
May 24, 2013
from PR Newswire
Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference
May 23, 2013
from PR Newswire
Amgen Announces Voting Results of Annual Meeting of Stockholders
May 22, 2013
from PR Newswire
RBCC Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
May 21, 2013
from Business Wire News Releases
Amgen To Present At The UBS Global Life Sciences Conference
May 16, 2013
from PR Newswire
Transgenomic Announces Global Availability of CRC RAScan™ Mutation Detection Test for Use in Patients with Metastatic Colorectal Cancer to Help Identify Appropriate Treatment
May 16, 2013
from Business Wire News Releases
New Analyses Identify Predictive Biomarkers For Vectibix® (Panitumumab) In Patients With Metastatic Colorectal Cancer
May 15, 2013
Biomarker Analysis From Phase 3 PRIME ('203) Study and Phase 2 PEAK ('509) Study Link Additional RAS Gene Mutations to Vectibix Clinical Response Read More
from PR Newswire
Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
May 15, 2013
from PR Newswire
RBCC Partner n3D Signs U.S. Distribution Agreement
May 13, 2013
from Business Wire News Releases
Strategy Behind Our Success, We Get in Early: PSX, AMGN, MPC and BAX
May 11, 2013
from Marketwired News Releases
Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
May 09, 2013
Goal Is to Bring Amgen's Vectibix® (Panitumumab) to Chinese Patients Read More
from PR Newswire
Amgen Announces Top-Line Results of Vectibix® (panitumumab) Phase 3 Head-to-Head Study Against Erbitux® (cetuximab) in Metastatic Colorectal Cancer
May 07, 2013
Study Meets Primary Endpoint of Non-Inferiority in Monotherapy Setting Read More
from PR Newswire
Transgenomic Signs Collaboration Agreement with Amgen for Development of CE-IVD CRC RAScan™ Mutation Detection Tests for Patients with Metastatic Colorectal Cancer
May 06, 2013
from Business Wire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
35 36 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
Boeing to Airbus: Game On
Nick Shchetko
2
The Future of Android Looks More Like Apple Inc.
Mike Schuster
3
Markets Take a Beating Post-Fed
Minyanville Staff
4
The Waning Integrity of US Financial Markets
Todd Harrison
5
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster